Fennec Pharmaceuticals, Inc. (FRX.TO)
14.76
0.00 (0.00%)
CAD |
TSX |
Oct 23, 16:00
Fennec Pharmaceuticals Net Income (Quarterly) : 2.731M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.731M |
| March 31, 2026 | 0.2757M |
| December 31, 2025 | -7.173M |
| September 30, 2025 | -0.8786M |
| June 30, 2025 | -4.365M |
| March 31, 2025 | -1.672M |
| December 31, 2024 | -2.264M |
| September 30, 2024 | -7.822M |
| June 30, 2024 | -7.598M |
| March 31, 2024 | 17.31M |
| December 31, 2023 | -3.653M |
| September 30, 2023 | -2.504M |
| June 30, 2023 | -7.312M |
| March 31, 2023 | -8.186M |
| December 31, 2022 | -9.309M |
| September 30, 2022 | -10.57M |
| June 30, 2022 | -6.476M |
| March 31, 2022 | -4.681M |
| December 31, 2021 | -5.581M |
| September 30, 2021 | -5.273M |
| June 30, 2021 | -4.912M |
| March 31, 2021 | -5.993M |
| December 31, 2020 | -4.219M |
| September 30, 2020 | -8.262M |
| June 30, 2020 | -6.712M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.146M |
| December 31, 2019 | -4.765M |
| September 30, 2019 | -2.389M |
| June 30, 2019 | -6.328M |
| March 31, 2019 | -3.491M |
| December 31, 2018 | -3.941M |
| September 30, 2018 | -3.593M |
| June 30, 2018 | -3.340M |
| March 31, 2018 | -1.983M |
| December 31, 2017 | -2.911M |
| September 30, 2017 | -2.948M |
| June 30, 2017 | -2.149M |
| March 31, 2017 | -1.067M |
| December 31, 2016 | -1.525M |
| September 30, 2016 | -0.6548M |
| June 30, 2016 | -0.9333M |
| March 31, 2016 | -0.577M |
| December 31, 2015 | -0.7211M |
| September 30, 2015 | -0.1609M |
| June 30, 2015 | -0.2127M |
| March 31, 2015 | 0.2197M |
| December 31, 2014 | 1.576M |
| September 30, 2014 | 0.4136M |
| June 30, 2014 | -0.818M |
| March 31, 2014 | -3.523M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bright Minds Biosciences, Inc. | -2.398M |
| Spectral Medical, Inc. | 0.331M |
| Resverlogix Corp. | -8.421M |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | -0.2796M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 24.74M |
| Total Expenses (Quarterly) | 22.01M |
| EPS Diluted (Quarterly) | 0.075 |
| Enterprise Value | 458.58M |
| Gross Profit Margin (Quarterly) | 95.97% |
| Profit Margin (Quarterly) | 11.04% |
| Earnings Yield | -1.21% |
| Normalized Earnings Yield | -0.7825 |